Hot Topics on Infections in the Critically Ill Patient, ESCMID Postgraduate Education Course
31 May - 01 June 2013 , Athens, Greece
Attention: Place of the course has been changed from Nafplio to Athens!
- ESCMID Study Group for Infections in Critically Ill Patients (ESGCIP)
- Hellenic Society of Chemotherapy
- Matteo Bassetti, Udine, Italy
- Helen Giamarellou, Athens, Greece
- Garyphallia Poulakou, Athens, Greece
- Jordi Rello, Barcelona, Spain
The course will present hot topics for physicians treating critically ill patients. The content will be organised roughly as hot topics in prevention, PK/PDs, treatment and developments on sepsis.
Attention: Course venue has changed!
New Course Venue
National School of Public Health
Alexandras Avenue 196
11521 Athens, Greece
40 – 80 infectious disease physicians, intensivists, pulmonologists, clinical microbiologists and critical care nurses.
Dr Garyphallia Poulakou
Attikon University General Hospital
1 Rimini st
Phone +30 21058 31990
Presentations are availabe in the ESCMID Online Lecture Library.
Friday, 31 May 2013
- Welcome – Opening remarks
Prevention strategies for critically ill patients
- Surveillance cultures for vulnerable populations: lessons from the MOSAR study
- The role of SDD: when and how?
- Infection control for neutropenic patients
- Prevention of catheter-related BSIs: is zero rate feasible?
- Coffee break
Hot topics on critically ill patients
- Innovation and research in VAP and tracheobronchitis: what does the future hold?
- Linezolid or vancomycin in the treatment of MRSA pneumonia: still existing dilemmas?
- Pre-emptive vs. empirical approach in Candida infections
PK/PD issues for the treatment of critically ill patients
- Basic concepts of PK/PD and pharmacokinetic variations in the critically ill patient
- Novel PK/PD data on the optimisation of colistin and carbapenems
Challenging infections in the ICU
- Clostridium difficile: battling the new enemy
- The real impact of aspergillosis in nonhaematological patients
- Coffee break
- An appraisal of the usefulness of guidelines in the management of severe infections
- Approaching intra-abdominal sepsis
- CNS infections in neurosurgical patients
- Closing remarks of the first day
Saturday, 1 June 2013
How to improve the therapeutic approach for the critically ill patient
- Combination or monotherapy in infectionsby MDR pathogens?
- The immunocompromised critically ill patient with MDR infection
- The revival of old antibiotics in the treatment of MDR infections
- A short overview of the drug development pipeline
- Coffee break
The strategic therapeutic approaches in themanagement of infections in critically ill patients
- Any room for de-escalation strategies? When and how?
- Any room for shortening of treatment duration? Current evidence
- Antibiotic stewardship in ICU
- Interactive case (to be announced)
Approaching sepsis for the critically ill patient in 2012
- The severely ill patient: what “modern management” imposes after the failure of most trials on immunointervention?
- Molecular footprinting of the invading microorganism
- Molecular footprinting of the host: is it achievable?
- I believe only in suPAR
- Closing remarks
Invited Faculty Members
- M. Akova, Ankara, Turkey
- A. Antoniadou, Athens, Greece
- A. Armaganidis, Athens, Greece
- M. Bassetti, Udine, Italy
- M. Bauer, Jena, Germany
- J. Chastre, Paris, France
- G. L. Daikos, Athens, Greece
- G. Dimopoulos, Athens, Greece
- E. J. Giamarellos-Bourboulis, Athens, Greece
- H. Giamarellou, Athens, Greece
- I. Karaiskos, Athens, Greece
- J. Kesecioglu, Utrecht, The Netherlands
- P. Montravers, Paris, France
- J. Paiva, Porto, Portugal
- F. Pea, Udine, Italy
- D. Plachouras, Athens, Greece
- G. Poulakou, Athens, Greece
- J. Rello, Barcelona, Spain
- J. Rodríguez-Baño, Seville, Spain
- J. F. Timsit, Grenoble, France
- D. Vogelaers, Gent, Belgium